✦ LIBER ✦

Secondary structure and signal assignments of human-immunodeficiency-virus-1 protease complexed to a novel, structure-based inhibitor

✍ Scribed by Toshimasa YAMAZAKI; Linda K. NICHOLSON; Dennis A. TORCHIA; Stephan J. STAHL; Joshua D. KAUFMAN; Paul T. WINGFIELD; Peter J. DOMAILLE; Sharon CAMPBELL-BURK

Book ID: 115131025
Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 609 KB
Volume: 219
Category: Article
ISSN: 1432-1327
DOI: 10.1111/j.1432-1033.1994.tb19987.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Structure Based Pre

ChemInform Abstract: Structure Based Prediction of Binding Affinity of Human Immunodeficiency Virus-1 Protease Inhibitors.

✍ Santosh S. Kulkarni; Vithal M. Kulkarni 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 2 views

ChemInform Abstract: A Novel, Picomolar

ChemInform Abstract: A Novel, Picomolar Inhibitor of Human Immunodeficiency Virus Type 1 Protease.

✍ H. L. SHAM; C. ZHAO; K. D. STEWART; D. A. BETEBENNER; S. LIN; C. H. PARK; X.-P. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB

Preparation and Structure−Activity Relat

Preparation and Structure−Activity Relationship of Novel P1/P1‘-Substituted Cyclic Urea-Based Human Immunodeficiency Virus Type-1 Protease Inhibitors

✍ Nugiel, David A.; Jacobs, Kim; Worley, Tabitha; Patel, Mona; Kaltenbach, Robert 📂 Article 📅 1996 🏛 American Chemical Society 🌐 English ⚖ 409 KB

ChemInform Abstract: Preparation and Str

ChemInform Abstract: Preparation and Structure-Activity Relationship of Novel P1/P1′- Substituted Cyclic Urea-Based Human Immunodeficiency Virus Type-1 Protease Inhibitors.

✍ D. A. NUGIEL; K. JACOBS; T. WORLEY; M. PATEL; R. F. III KALTENBACH; D. T. MEYER; 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 40 KB

Comparison of inhibitor binding to felin

Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: Structure-based drug design and the resistance problem

✍ Ben M. Dunn; Michael W. Pennington; D. Constanza Frase; Kevin Nash 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 843 KB

The design and synthesis of compounds targeted against human immunodeficiency virus 1 (HIV-1) protease have resulted in effective antiviral therapies. However, the rapid replication of the virus and the inherent mutability of the viral genome result in the outgrowth of resistant strains in the major

Antiviral activity and cross-resistance

Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor

✍ G. Sévigny; B. Stranix; B. Tian; A. Dubois; G. Sauvé; C. Petropoulos; Y. Lie; N. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 118 KB